Unbound MEDLINE

Biperiden enhances L-DOPA methyl ester and dopamine D(l) receptor agonist SKF-82958 but antagonizes D(2)/D(3) receptor agonist rotigotine antihemiparkinsonian actions. European journal of pharmacology [Eur J Pharmacol] Journal article

 
TitleBiperiden enhances L-DOPA methyl ester and dopamine D(l) receptor agonist SKF-82958 but antagonizes D(2)/D(3) receptor agonist rotigotine antihemiparkinsonian actions.
Author(s)Domino EF, Ni L 
InstitutionDepartment of Pharmacology, University of Michigan, Ann Arbor, MI 49109-0632, United States. efdabcde@umich.edu
SourceEur J Pharmacol 2008 Dec 3; 599(1-3):81-5.
MeSH1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Animals
Antiparkinson Agents
Behavior, Animal
Benzazepines
Biperiden
Disease Models, Animal
Dopamine Agonists
Dose-Response Relationship, Drug
Drug Interactions
Female
Levodopa
Macaca nemestrina
Muscarinic Antagonists
Parkinsonian Disorders
Receptors, Dopamine D1
Receptors, Dopamine D2
Receptors, Dopamine D3
Tetrahydronaphthalenes
Thiophenes
AbstractThe effects of biperiden (0, 100, and 320 microg/kg), a selective muscarinic M(1)/M(4) receptor cholinergic antagonist, were studied alone and in combination with those of L-DOPA methyl ester (16.7 mg/kg), a selective dopamine D(1) receptor agonist SKF-82958 (74.8 microg/kg), or a selective D(2)/D(3) receptor agonist rotigotine (32 microg/kg) on circling behavior in MPTP induced hemiparkinsonian monkeys. The doses selected were given i.m. in approximately equieffective doses to produce contraversive circling. Biperiden alone with 5% dextrose vehicle produced a slight increase in contraversive circling in a dose related manner. When combined with L-DOPA methyl ester, it enhanced contraversive circling and decreased ipsiversive circling. When biperiden was combined with SKF-82958, contraversive circling also was enhanced and ipsiversive circling decreased. Exactly the opposite was observed with the combination of biperiden and rotigotine. The results indicate a dramatic difference in effects of a prototypic muscarinic M(1)/M(4) receptor cholinergic antagonist in combination with prototypic full dopamine D(1) or D(2)/D(3) receptor agonists. Biperiden interactions with L-DOPA methyl ester were more predominantly D(l) than D(2)/D(3) receptor-like in this animal model of hemiparkinsonism.
Languageeng
Pub Type(s)Journal Article
Research Support, Non-U.S. Gov't
PubMed ID18851961
  
Advertise on this site.